azathioprine has been researched along with Allergic Angiitis in 48 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
" This study was undertaken to determine whether the addition of azathioprine (AZA) to glucocorticoids could achieve a higher sustained remission rate of newly diagnosed nonsevere eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA), microscopic polyangiitis (MPA), or polyarteritis nodosa (PAN)." | 9.24 | Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial. ( Agard, C; Baron, G; Bienvenu, B; Bourgarit, A; Cohen, P; Crestani, B; Delbrel, X; Diot, E; Geffray, L; Godmer, P; Groh, M; Guillevin, L; Le Guern, V; Le Jeunne, C; Lifermann, F; Limal, N; Liozon, E; Mékinian, A; Mouthon, L; Néel, A; Pagnoux, C; Papo, T; Puéchal, X; Quémeneur, T; Ravaud, P; Ruivard, M; Ruppert, AM; Sailler, L; Saraux, JL; Terrier, B, 2017) |
" This study was undertaken to determine whether the addition of azathioprine (AZA) to glucocorticoids could achieve a higher sustained remission rate of newly diagnosed nonsevere eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA), microscopic polyangiitis (MPA), or polyarteritis nodosa (PAN)." | 5.24 | Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial. ( Agard, C; Baron, G; Bienvenu, B; Bourgarit, A; Cohen, P; Crestani, B; Delbrel, X; Diot, E; Geffray, L; Godmer, P; Groh, M; Guillevin, L; Le Guern, V; Le Jeunne, C; Lifermann, F; Limal, N; Liozon, E; Mékinian, A; Mouthon, L; Néel, A; Pagnoux, C; Papo, T; Puéchal, X; Quémeneur, T; Ravaud, P; Ruivard, M; Ruppert, AM; Sailler, L; Saraux, JL; Terrier, B, 2017) |
"To assess the efficacy of systemic corticosteroids (CS) alone as first-line treatment in patients with Churg-Strauss syndrome (CSS) without poor-prognosis factors, as defined by the Five-Factors Score (FFS), and to compare the efficacy and safety of oral azathioprine (AZA) versus intravenous pulse cyclophosphamide (CYC) as adjuvant immunosuppressive therapy for treatment failure or relapse." | 5.13 | Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. ( Arène, JP; Cohen, P; Cordier, JF; Delaval, P; Guillevin, L; Lauque, D; Letellier, P; Mahr, A; Pagnoux, C; Puéchal, X; Ribi, C, 2008) |
" Renewed remission was obtained with additional infliximab, and was maintained with azathioprine for 12 months before the patient again presented with symmetrical polyarthritis." | 3.73 | [Symmetric polyarthritis in a patient with Churg-Strauss syndrome]. ( Aries, PM; Reinhold-Keller, E, 2005) |
"In addition, Behcet's syndrome appears to be more common than previously assumed and is likely more common than a combination of ANCA-associated vasculitis (AAV) syndromes." | 2.45 | Necrotizing vasculitis--a 2009 update. ( Sharaf, PH; Yazici, Y, 2009) |
"Patients with Wegener's granulomatosis or microscopic polyangiitis or Churg-Strauss syndrome and one or more poor prognostic factors must receive a combination of corticosteroids and immunosuppressants, mainly intravenous pulsed cyclophosphamide." | 2.44 | [Treatment of ANCA-associated vascularitides]. ( Guillevin, L; Pagnoux, C, 2007) |
"MPO-ANCA-associated vasculitis is more frequent in Japan, whereas PR3-ANCA-associated vasculitis is more common in Europe and USA." | 2.44 | ANCA-associated vasculitis: diagnostic and therapeutic strategy. ( Ozaki, S, 2007) |
"Among 33 cases, 25 were diagnosed as Wegener granulomatosis (WG), seven as microscopic polyangitis (MPA) and one as Churg-Strauss syndrome (SCS)." | 1.38 | Clinical features and outcomes of ANCA-associated renal vasculitis. ( Brunet, P; Burtey, S; Dussol, B; Seck, SM, 2012) |
"A 52-year-old woman with a history of chronic obstructive pulmonary disease presented with symmetrical polyarthritis involving her metacarpophalangeal and proximal interphalangeal joints, knees, ankles, and hips and with a purpuric rash involving her lower extremities." | 1.32 | Churg-Strauss syndrome: diagnostic difficulties and pathogenesis. ( Buscemi, DM; Diri, E; Nugent, KM, 2003) |
"To report asymptomatic optic disc edema in a patient with Churg-Strauss syndrome." | 1.32 | Asymptomatic optic neuropathy associated with Churg-Strauss syndrome. ( Foroozan, R; Rosenblatt, BJ; Savino, PJ, 2003) |
"Intra-pericardial thrombosis is usually due to haemorrhage into the pericardial space or after traumatic pericardiocentesis." | 1.32 | Churg-Strauss syndrome as an unusual cause of spontaneous atraumatic intra-pericardial thrombosis. ( Carruthers, DM; Lau, EW; Prasad, N, 2004) |
"Azathioprine (AZA) is characterized by high interindividual differences in bioavailability and metabolization." | 1.31 | Relationship between red cell mean corpuscular volume and 6-thioguanine nucleotides in patients treated with azathioprine. ( Decaux, G; Desager, JP; Horsmans, Y; Prospert, F, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.08) | 18.7374 |
1990's | 4 (8.33) | 18.2507 |
2000's | 22 (45.83) | 29.6817 |
2010's | 19 (39.58) | 24.3611 |
2020's | 2 (4.17) | 2.80 |
Authors | Studies |
---|---|
Salvador, F | 1 |
Rasheed, N | 1 |
Ahuja, R | 1 |
Borneo, H | 1 |
Ameneiros-Lago, E | 1 |
Pérez-Valcarcel, J | 1 |
Fernández-Fernández, FJ | 1 |
Caínzos-Romero, T | 1 |
Puéchal, X | 3 |
Pagnoux, C | 6 |
Baron, G | 2 |
Quémeneur, T | 2 |
Néel, A | 2 |
Agard, C | 2 |
Lifermann, F | 2 |
Liozon, E | 1 |
Ruivard, M | 2 |
Godmer, P | 1 |
Limal, N | 2 |
Mékinian, A | 1 |
Papo, T | 1 |
Ruppert, AM | 1 |
Bourgarit, A | 1 |
Bienvenu, B | 1 |
Geffray, L | 2 |
Saraux, JL | 2 |
Diot, E | 1 |
Crestani, B | 1 |
Delbrel, X | 1 |
Sailler, L | 1 |
Cohen, P | 3 |
Le Guern, V | 1 |
Terrier, B | 2 |
Groh, M | 1 |
Le Jeunne, C | 2 |
Mouthon, L | 2 |
Ravaud, P | 2 |
Guillevin, L | 6 |
Smitienko, I | 1 |
Novikov, P | 1 |
Moiseev, S | 1 |
Navarro-Mendoza, EP | 1 |
Tobón, GJ | 1 |
Saku, A | 1 |
Furuta, S | 1 |
Hiraguri, M | 1 |
Ikeda, K | 1 |
Kobayashi, Y | 1 |
Kagami, SI | 1 |
Kurasawa, K | 1 |
Matsumura, R | 1 |
Nakagomi, D | 1 |
Sugiyama, T | 1 |
Umibe, T | 1 |
Watanabe, N | 1 |
Nakajima, H | 1 |
Wislez, M | 1 |
Cottin, V | 1 |
Aouba, A | 1 |
Bonnotte, B | 1 |
Lee, JJY | 1 |
Alsaleem, A | 1 |
Chiang, GPK | 1 |
Limenis, E | 1 |
Sontichai, W | 1 |
Yeung, RSM | 1 |
Akikusa, J | 1 |
Laxer, RM | 1 |
Lin, YC | 1 |
Oliveira, GH | 1 |
Villa-Forte, A | 1 |
Glaveckaite, S | 1 |
Valeviciene, N | 1 |
Palionis, D | 1 |
Kontrimaviciute, E | 1 |
Lesinskas, E | 1 |
Yoshida, M | 1 |
Vanoni, F | 1 |
Bettinelli, A | 1 |
Keller, F | 1 |
Bianchetti, MG | 1 |
Simonetti, GD | 1 |
Fallah Tafti, S | 1 |
Mokri, B | 1 |
Mansoori, N | 1 |
Henes, J | 1 |
Horger, M | 1 |
Kanz, L | 1 |
Kötter, I | 2 |
Sharaf, PH | 1 |
Yazici, Y | 1 |
Adema, AY | 1 |
Schilder, AM | 1 |
Schreuder, TC | 1 |
Grünberg, K | 1 |
Bultink, IE | 1 |
Mulder, CJ | 1 |
Lehmann, P | 1 |
Fleck, M | 1 |
Schoelmerich, J | 1 |
Haerle, P | 1 |
Cohen Tervaert, JW | 1 |
Stegeman, CA | 1 |
Daumas, A | 1 |
Bernard, F | 1 |
Jacquier, A | 1 |
Rossi, P | 1 |
Francès, Y | 1 |
Granel, B | 1 |
Dunogué, B | 1 |
Irioka, T | 1 |
Mizusawa, H | 1 |
Seck, SM | 1 |
Dussol, B | 1 |
Brunet, P | 1 |
Burtey, S | 1 |
Moosig, F | 1 |
Bremer, JP | 1 |
Hellmich, B | 1 |
Holle, JU | 1 |
Holl-Ulrich, K | 1 |
Laudien, M | 1 |
Matthis, C | 1 |
Metzler, C | 1 |
Nölle, B | 1 |
Richardt, G | 1 |
Gross, WL | 1 |
Schmid, G | 1 |
Schmid, L | 1 |
Fischer, A | 1 |
Della Rossa, A | 1 |
Baldini, C | 1 |
Tavoni, A | 1 |
Tognetti, A | 1 |
Neglia, D | 1 |
Sambuceti, G | 1 |
Puccini, R | 1 |
Colangelo, C | 1 |
Bombardieri, S | 1 |
Diri, E | 1 |
Buscemi, DM | 1 |
Nugent, KM | 1 |
Rosenblatt, BJ | 1 |
Foroozan, R | 1 |
Savino, PJ | 1 |
Lau, EW | 1 |
Carruthers, DM | 1 |
Prasad, N | 1 |
Lamprecht, P | 1 |
Aries, PM | 1 |
Reinhold-Keller, E | 1 |
Dixit, RK | 1 |
Ferenczi, K | 1 |
Chang, T | 1 |
Camouse, M | 1 |
Han, R | 1 |
Stern, R | 1 |
Willis, J | 1 |
Cooper, KD | 1 |
Gilliam, AC | 1 |
Ozaki, S | 1 |
Delplace, D | 1 |
da Costa, LM | 1 |
Goffin, L | 1 |
Wechsler, ME | 1 |
Sass, U | 1 |
André, J | 1 |
Dangoisse, C | 1 |
Song, M | 1 |
Ribi, C | 1 |
Mahr, A | 1 |
Arène, JP | 1 |
Lauque, D | 1 |
Letellier, P | 1 |
Delaval, P | 1 |
Cordier, JF | 1 |
Bargagli, E | 1 |
Madioni, C | 1 |
Olivieri, C | 1 |
Penza, F | 1 |
Rottoli, P | 1 |
Cormio, G | 1 |
Cramarossa, D | 1 |
Di Vagno, G | 1 |
Masciandaro, A | 1 |
Loverro, G | 1 |
Meyer, T | 1 |
Verwiebe, R | 1 |
Lorch, H | 1 |
Kreuzer, H | 1 |
Figulla, HR | 1 |
Stübiger, N | 1 |
Schlote, T | 1 |
Zierhut, M | 1 |
Decaux, G | 1 |
Prospert, F | 1 |
Horsmans, Y | 1 |
Desager, JP | 1 |
Solans, R | 1 |
Bosch, JA | 1 |
Pérez-Bocanegra, C | 1 |
Selva, A | 1 |
Huguet, P | 1 |
Alijotas, J | 1 |
Orriols, R | 1 |
Armadans, L | 1 |
Vilardell, M | 1 |
Day, C | 1 |
Savage, C | 1 |
Vemuri, P | 1 |
Greenberger, PA | 1 |
Patterson, R | 1 |
Clutterbuck, EJ | 1 |
Evans, DJ | 1 |
Pusey, CD | 1 |
Engelhardt, A | 1 |
Thron, C | 1 |
Glötzner, FL | 1 |
Neundörfer, B | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) Without Poor Prognosis Factors[NCT00647166] | Phase 3 | 114 participants (Actual) | Interventional | 2008-05-31 | Completed | ||
CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors: a Prospective Randomized Study in 72 Patients.[NCT00399399] | Phase 4 | 72 participants | Interventional | 1996-07-31 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
12 reviews available for azathioprine and Allergic Angiitis
Article | Year |
---|---|
ANCA associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; | 2020 |
Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Glucocort | 2018 |
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathio | 2019 |
[Treatment of systemic vasculitides].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Azathioprine; Ch | 2008 |
[Strategy of immunosuppressants usage for subjects with loss of renal function and infection control on RPGN].
Topics: Autoantibodies; Azathioprine; Churg-Strauss Syndrome; Contraindications; Cyclophosphamide; Cyclospor | 2009 |
Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood.
Topics: Adolescent; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil C | 2010 |
Necrotizing vasculitis--a 2009 update.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Behcet Syndrome; Churg-Str | 2009 |
[New aspects in ANCA-associated vasculitides].
Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Autoantigens; Azathioprine; CD28 Antigens; Churg-St | 2004 |
[Treatment of ANCA-associated vascularitides].
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, | 2007 |
ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biological Products; | 2007 |
[Churg-Strauss syndrome].
Topics: Azathioprine; Churg-Strauss Syndrome; Diagnosis, Differential; Drug Combinations; Female; Humans; Mi | 1999 |
Primary systemic vasculitis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Churg-Strauss | 2001 |
2 trials available for azathioprine and Allergic Angiitis
Article | Year |
---|---|
Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
Topics: Adult; Aged; Asthma; Azathioprine; Churg-Strauss Syndrome; Disease Progression; Double-Blind Method; | 2017 |
Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Disease-F | 2008 |
34 other studies available for azathioprine and Allergic Angiitis
Article | Year |
---|---|
Polyangiitis overlap syndrome: a novel presentation of microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Fema | 2021 |
Colitis as a form of presentation of eosinophilic granulomatosis with polyangiitis.
Topics: Aged; Azathioprine; Churg-Strauss Syndrome; Colitis; Colonoscopy; Female; Humans; Immunosuppressive | 2018 |
Does the revised definition of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) indicate the need for a new treatment? Comment on the article by Puéchal et al.
Topics: Azathioprine; Churg-Strauss Syndrome; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Mic | 2018 |
Longterm Outcomes of 188 Japanese Patients with Eosinophilic Granulomatosis with Polyangiitis.
Topics: Aged; Azathioprine; Churg-Strauss Syndrome; Eosinophils; Female; Humans; Immunosuppressive Agents; J | 2018 |
Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.
Topics: Adult; Aged; Asthma; Azathioprine; Churg-Strauss Syndrome; Disease Progression; Disease-Free Surviva | 2019 |
Churg-Strauss syndrome and persistent heart failure: active disease or damage?
Topics: Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy, Combination; Female; Heart Fai | 2013 |
Heart involvement in Churg-Strauss syndrome.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Drug Therapy, Combination; Fe | 2017 |
Churg Strauss Syndrome after polypectomy in asthmatic and allergic patients.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Humans; Immunosuppressive Age | 2009 |
[56-year-old patient with leg paresis, pulmonary infiltrates, and eosinophilia--Case 08/2009].
Topics: Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antinuclear; Azathioprine; Churg-Strauss Syndrom | 2009 |
Ascites as the presenting symptom in a patient with Churg-Strauss syndrome.
Topics: Aged; Ascites; Asthma; Azathioprine; Biopsy; Churg-Strauss Syndrome; Drug Therapy, Combination; Dysp | 2010 |
Azathioprine-associated hypersensitivity reaction in a patient with Churg Strauss vasculitis.
Topics: Azathioprine; Churg-Strauss Syndrome; Drug Hypersensitivity; Humans; Immunosuppressive Agents; Male; | 2010 |
[Churg-Strauss syndrome: diagnosis and treatment].
Topics: Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy, Comb | 2011 |
[Eosinophilic myopericarditis revealing a Churg-Strauss syndrome].
Topics: Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combi | 2011 |
Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.
Topics: Adrenal Cortex Hormones; Asthma; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Diagnosis, | 2011 |
Hemorrhagic bulla in Churg-Strauss syndrome.
Topics: Adrenal Cortex Hormones; Azathioprine; Churg-Strauss Syndrome; Hemorrhage; Humans; Leg; Male; Middle | 2011 |
Clinical features and outcomes of ANCA-associated renal vasculitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated V | 2012 |
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
Topics: Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Cohort Studies; Cyclophosphamide; Fe | 2013 |
[Churg-Strauss syndrome--an interdisciplinary challenge].
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Cooperative Behavior; Diagnosi | 2012 |
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre.
Topics: Adult; Aged; Azathioprine; Biopsy, Needle; Churg-Strauss Syndrome; Cyclophosphamide; Dose-Response R | 2002 |
Churg-Strauss syndrome: diagnostic difficulties and pathogenesis.
Topics: Antirheumatic Agents; Arthritis; Azathioprine; Churg-Strauss Syndrome; Female; Humans; Middle Aged; | 2003 |
Asymptomatic optic neuropathy associated with Churg-Strauss syndrome.
Topics: Azathioprine; Biopsy; Churg-Strauss Syndrome; Drug Therapy, Combination; Female; Glucocorticoids; Hu | 2003 |
Churg-Strauss syndrome as an unusual cause of spontaneous atraumatic intra-pericardial thrombosis.
Topics: Adult; Azathioprine; Churg-Strauss Syndrome; Combined Modality Therapy; Echocardiography, Doppler; F | 2004 |
[Symmetric polyarthritis in a patient with Churg-Strauss syndrome].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Azathioprine; Churg-Strauss Syndrome; Cyclo | 2005 |
Case 28-2005: a case of systemic necrotizing vasculitis.
Topics: Adult; Asthma; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Administration Schedule; | 2005 |
A case of Churg-Strauss syndrome associated with antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Azathioprine; Biopsy, Needle; Churg-Strauss Syndrome; Disease Progress | 2007 |
Oral ulceration: an unusual manifestation of Churg-Strauss syndrome.
Topics: Adolescent; Azathioprine; Churg-Strauss Syndrome; Diagnosis, Differential; Female; Glucocorticoids; | 2007 |
Churg-Strauss vasculitis in a patient treated with omalizumab.
Topics: Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, H | 2008 |
Successful pregnancy in a patient with Churg-Strauss syndrome.
Topics: Adult; Asthma; Azathioprine; Churg-Strauss Syndrome; Female; Humans; Male; Prednisone; Pregnancy; Pr | 1995 |
[Involvement of the pericardium in Churg-Strauss syndrome].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy | 1994 |
Relationship between red cell mean corpuscular volume and 6-thioguanine nucleotides in patients treated with azathioprine.
Topics: Adult; Azathioprine; Biological Availability; Churg-Strauss Syndrome; Erythrocyte Indices; Erythrocy | 2000 |
Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Azathioprine; Churg-Strauss Syndrome; Cyclophosp | 2001 |
Churg-Strauss syndrome: survival for 26 years.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Asthma; Azathioprine; Churg-Strauss Syndrome; Fatal | 2002 |
Renal involvement in Churg-Strauss syndrome.
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Child, Preschool; Churg-Strauss Syndrome; Cycl | 1990 |
[Polyneuropathy in Churg-Strauss syndrome].
Topics: Aged; Asthma; Azathioprine; Biopsy; Blood Sedimentation; Chronic Disease; Churg-Strauss Syndrome; Dr | 1989 |